Phase 1 dose escalation study expected in 3Q 2026 Cash balance of $38.8 million as of September 30, 2025 anticipated to fund key milestones into 2027 REDWOOD CITY, Calif., Nov. 12, 2025 (GLOBE ...
Neptune Insurance Holdings Inc. ("Neptune" or the "Company") (NYSE: NP), the parent company of Neptune Flood Incorporated, ...
Researchers have identified a specific genus in the mouse microbiome that aids weight loss, providing another potential route ...
An undergraduate student in the College of Agriculture and Life Sciences helped build the first 3D turkey cecal organoids, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback